Mullein (Verbascum thapsus)

Verbascum thapsus
Evidence Level
Preliminary
2 Clinical Trials
5 Documented Benefits
1/5 Evidence Score

Mullein is a woolly-leaved plant of roadsides and pastures whose flowers and leaves have long been brewed for coughs and chest complaints in European folk medicine. It is sold today as dried leaf and flower tea, capsules, alcohol extracts and flower oil. The European Medicines Agency accepts mullein flower tea only as a traditional herbal medicine to relieve sore throat with dry cough and cold, based on long-standing use; its assessors found no clinical studies, and a 2024 review of newer literature found nothing that changed that. No published trial has compared mullein taken by mouth with a placebo or other control. The antiviral, anti-inflammatory and expectorant claims rest on cell and animal work. In the US it is sold as a dietary supplement, and federal food-additive rules list mullein flowers (V. phlomoides and V. thapsiforme) as a natural flavoring for alcoholic beverages only.

Studied Dose No clinical dose exists. The EU traditional-use monograph lists 1.5 to 2 g of dried flower in 150 mL of boiling water as a tea, 3 to 4 times daily (4.5 to 8 g a day), for adolescents and adults, with a doctor consulted if symptoms last over a week.
Active Compound Mucilage polysaccharides, iridoids (aucubin, catalpol), verbascoside, triterpene saponins, flavonoids

Benefits

Traditional throat-soothing tea in European herbal use

Mullein flower tea is registered in the European Union as a traditional herbal medicine for sore throat that comes with a dry cough and cold. That status rests on at least 30 years of documented use, 15 of them within the EU, rather than on trials: the regulator found no clinical data. No study has measured whether the tea eases or shortens a cold.

Mucilage content behind its traditional demulcent use

The flowers contain roughly 2 to 3 percent water-soluble polysaccharides, and pharmacopoeia-grade flower must swell in water to a set minimum. EU reviewers concluded that mullein's traditional role in cough and cold is chiefly as a demulcent, a slippery film over an irritated throat. The proposed effect is a local coating; no study has measured it in people.

Expectorant use and laboratory tests of mucus transport

Traditional herbals call mullein an expectorant that loosens chest mucus, usually crediting its saponins. In the only mucus-transport test EU reviewers could find, a water extract of the flower did not change mucociliary transport in isolated frog ciliated tissue, and saponins have not been confirmed in one of the three official flower species. No human study has measured mucus clearance.

Respiratory virus activity seen only in cell culture

A freeze-dried infusion of mullein flowers lowered influenza A and B virus titers by 1 to 3 log units in cell culture and directly inactivated herpes simplex virus, though it did not inactivate influenza particles. No study has tested whether drinking the tea changes the course of a cold or flu in a person.

Anti-inflammatory activity in cell and animal studies

A polyphenol-rich flower extract cut an inflammatory adhesion molecule by more than half in human endothelial cells, but the same extract did not reduce paw swelling in rats. Isolated constituents such as verbascoside and aucubin reduced paw swelling in rats at oral doses of 100 to 150 mg per kilogram, far more than the 12 mg or less of either found in 2 g of flower.

Mechanism of action

1

Mucilage polysaccharides and throat coating

Mullein flower holds about 2 to 3 percent water-soluble acidic polysaccharides, mainly a highly branched arabinogalactan, plus a neutral arabinogalactan and a xyloglucan. In hot water these swell into a viscous solution that can coat the mouth and throat, the proposed basis of the soothing, demulcent use.

2

Saponins and the expectorant theory

Triterpene saponins such as verbascosaponin and the thapsuins have been isolated from mullein flowers and are the usual explanation for an expectorant effect. The only published content figure is tiny and methodologically weak, none were confirmed in V. densiflorum flowers, and a flower extract did not alter mucociliary transport in vitro.

3

Iridoids and phenylethanoid glycosides

The flowers carry iridoid glycosides such as aucubin and catalpol and the phenylethanoid verbascoside; in cell studies verbascoside and related phenylethanoids dampen nitric oxide and leukotriene production. Amounts vary widely by species: verbascoside is about 0.6 percent of V. densiflorum flower but only a trace in V. phlomoides.

4

Direct antiviral and antibacterial action in vitro

In cell culture, flower infusions reduced influenza virus yields and inactivated herpes simplex virus, and extracts inhibited several bacteria in dish assays. These effects come from extract applied straight to cells or microbes; absorption and blood levels after drinking mullein have never been measured.

Clinical trials

1
Mullein Flower Infusion Against Influenza and Herpes Viruses in Cell Culture
PubMed

Laboratory study of a lyophilized flower infusion of Verbascum thapsiforme; no human participants (Zgórniak-Nowosielska et al. 1991, Arch Immunol Ther Exp (Warsz))

Cell cultures infected with fowl plague virus, several influenza A strains, an influenza B strain and herpes simplex virus.

Influenza titers fell by 1 to 3 log units and herpes simplex titers by 2.3 log. The infusion inactivated herpes simplex virus directly at 300 micrograms per mL but did not inactivate influenza virus. No human study has tested these effects.

2
Polyphenol-Rich Mullein Flower Extract and Inflammation in Cells and Rats
PubMed

Laboratory and animal study of a water and n-butanol extract of Verbascum phlomoides flowers; no human participants (Grigore et al. 2013, Pharm Biol)

Human umbilical vein endothelial cells stimulated with TNF-alpha, and a rat paw edema model.

The extract contained 4.18 percent total polyphenols, mainly caffeic, ferulic and rosmarinic acids and quercetin; acteoside was not detected and aucubin appeared only in traces. It lowered ICAM-1 expression by 55 to 58.8 percent in cells at 100 and 200 micrograms per mL but did not reduce paw edema in rats. The authors judged the polyphenols to have only a weak influence on anti-inflammatory activity.

Side effects and drug interactions

Common Potential side effects

The EU monograph lists no known side effects; its assessors judged that there were not enough safety data to list any.
WHO pharmacovigilance data to November 2017 held one suspected hepatitis report for single-ingredient mullein; stop and seek care if jaundice or dark urine appears.
Skin reactions: occupational airborne dermatitis has been reported in a person exposed to mullein (V. densiflorum) at work.
Not recommended for children under 12 or during pregnancy and breastfeeding, because safety has not been established.
Genotoxicity of the flower is untested: isolated verbascoside damaged chromosomes in human lymphocytes in a test tube, while a methanolic mullein extract did not raise micronuclei in mouse bone marrow.
The EU monograph advises seeing a doctor for breathlessness, fever, pus-like sputum, worsening symptoms, or symptoms lasting more than a week.

Important Drug interactions

No interaction studies exist and the EU monograph reports none; the points below are precautions, not documented events.
Asthma and COPD inhalers: no study has shown a bronchodilator effect for mullein, and it should not replace a reliever or controller inhaler.
Sedatives, including benzodiazepines and sedating antihistamines: weak sedation from the mullein constituent verbascoside in mice makes a small additive effect theoretically possible.
Drugs with known liver toxicity, such as methotrexate or high-dose acetaminophen: combine cautiously given one suspected hepatitis report.
Influenza antivirals such as amantadine: a flower infusion combined with amantadine derivatives inhibited influenza virus more in cell culture, which says nothing about use in people; mullein is no substitute for a prescribed antiviral.

Frequently asked questions about Mullein (Verbascum thapsus)

Has mullein taken by mouth been tested in human trials?

No published trial has compared mullein taken by mouth with a placebo or other control. The European Medicines Agency found no clinical studies when it assessed mullein flower, and its 2024 review of newer literature found nothing relevant. The published randomized human studies that include mullein applied it to the body surface, not by mouth: herbal ear drops combining several plants in children, and a mullein cream on episiotomy wounds. A maker-sponsored, placebo-controlled trial of a mullein leaf and chlorophyll liquid (NCT07740746) is listed as completed in August 2025, but no results had been posted or published as of October 2026.

Which part of mullein is used, the flower or the leaf?

Both have folk-medicine histories, and US products include dried leaves and flowers, capsules, alcohol extracts and flower oil. The EU herbal monograph covers only the dried flower of three species: Verbascum thapsus, V. densiflorum (also called V. thapsiforme) and V. phlomoides. Constituents differ by species and plant part, so a leaf product is not the same material the EU monograph describes.

How is mullein flower tea prepared under the EU monograph?

The monograph describes 1.5 to 2 g of dried, cut flower steeped in 150 mL of boiling water as an infusion, taken three to four times a day, for adolescents and adults. It advises seeing a doctor if symptoms last longer than a week or worsen, or if breathlessness, fever or pus-like sputum appear.

Can children or pregnant women use mullein?

The EU monograph does not recommend mullein for children under 12, because adequate data are lacking, and does not recommend it during pregnancy or breastfeeding, because safety has not been established. Tests on reproductive toxicity and genotoxicity of the flower have not been performed. Anyone in these groups should ask a healthcare provider first.

What is Mullein?

Mullein is a woolly-leaved plant of roadsides and pastures whose flowers and leaves have long been brewed for coughs and chest complaints in European folk medicine. It is sold today as dried leaf and flower tea, capsules, alcohol extracts and flower oil.

What is Mullein used for?

NutraSmarts does not list Mullein under a health category. What the research covers: Mullein flower tea is registered in the European Union as a traditional herbal medicine for sore throat that comes with a dry cough and cold.

What is the recommended dosage of Mullein?

No clinical dose exists. The EU traditional-use monograph lists 1.5 to 2 g of dried flower in 150 mL of boiling water as a tea, 3 to 4 times daily (4.5 to 8 g a day), for adolescents and adults, with a doctor consulted if symptoms last over a week. Always follow the product label and check with a healthcare provider for personal advice.

Is Mullein safe, and does it have side effects?

Side effects and cautions reported for Mullein include: The EU monograph lists no known side effects; its assessors judged that there were not enough safety data to list any. WHO pharmacovigilance data to November 2017 held one suspected hepatitis report for single-ingredient mullein; stop and seek care if jaundice or dark urine appea… It may also interact with some medications. Mullein is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Mullein interact with any medications?

Possible interactions include: No interaction studies exist and the EU monograph reports none; the points below are precautions, not documented events. Asthma and COPD inhalers: no study has shown a bronchodilator effect for mullein, and it should not replace a reliever or controller inhaler. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Mullein?

NutraSmarts rates the evidence for Mullein as Preliminary (1 out of 5). It is backed by 2 study summaries and 15 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(15 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Turker AU, Gurel E. Common mullein (Verbascum thapsus L.): recent advances in research. Phytother Res. 2005;19(9):733-9. doi: 10.1002/ptr.1653.PubMedUsed to support: A review describing mullein's traditional use for pulmonary problems, asthma and spasmodic coughs, and its sale in US health stores as dried leaves and flowers, capsules, alcohol extracts and flower oil. Supports the background and product-form statements on this page.
  2. Gupta A, Atkinson AN, Pandey AK, Bishayee A. Health-promoting and disease-mitigating potential of Verbascum thapsus L. (common mullein): A review. Phytother Res. 2022;36(4):1507-1522. doi: 10.1002/ptr.7393.PubMedUsed to support: An updated review listing mullein's constituents (flavonoids, iridoids, phenylethanoid and phenylpropanoid glycosides, saponins) and its antiviral, antioxidant, anti-inflammatory, sedative, antibacterial and other activities, which the authors attribute to experimental studies rather than human trials.
  3. Zgórniak-Nowosielska I, Grzybek J, Manolova N, Serkedjieva J, Zawilińska B. Antiviral activity of Flos verbasci infusion against influenza and Herpes simplex viruses. Arch Immunol Ther Exp (Warsz). 1991;39(1-2):103-8..PubMedUsed to support: The cell-culture antiviral data on this page: a lyophilized flower infusion lowered influenza A and B titers by 1 to 3 log units and herpes simplex titers by 2.3 log, and was virucidal against herpes simplex but not influenza. No human participants.
  4. Grigore A, Colceru-Mihul S, Litescu S, Panteli M, Rasit I. Correlation between polyphenol content and anti-inflammatory activity of Verbascum phlomoides (mullein). Pharm Biol. 2013;51(7):925-9. doi: 10.3109/13880209.2013.767361.PubMedUsed to support: A flower extract with 4.18 percent polyphenols inhibited TNF-alpha-induced ICAM-1 expression by 55 to 58.8 percent in endothelial cells but did not reduce rat paw edema; the authors judged the polyphenols' anti-inflammatory influence weak. Supports the laboratory findings on inflammation described here.
  5. Sarrell EM, Cohen HA, Kahan E. Naturopathic treatment for ear pain in children. Pediatrics. 2003;111(5 Pt 1):e574-9. doi: 10.1542/peds.111.5.e574.PubMedUsed to support: A randomized double-blind trial in 171 children of multi-herb ear drops containing mullein versus anesthetic drops, with or without amoxicillin; pain improved in all groups, results were better with the herbal drops, and the authors attributed most of the improvement to time. A topical, multi-ingredient study, cited to show that the published randomized human data involving mullein do not involve oral use.
  6. Santoro A, Bianco G, Picerno P, Aquino RP, Autore G, Marzocco S, Gazzerro P, Lioi MB, Bifulco M. Verminoside- and verbascoside-induced genotoxicity on human lymphocytes: involvement of PARP-1 and p53 proteins. Toxicol Lett. 2008;178(2):71-6. doi: 10.1016/j.toxlet.2008.02.006.PubMedUsed to support: In human lymphocytes in vitro, verbascoside and verminoside increased chromosome aberrations and sister chromatid exchanges and lowered the mitotic index, with caffeic acid from verbascoside breakdown the likely driver. A test-tube finding on an isolated constituent, not on mullein tea.
  7. Escobar FM, Sabini MC, Zanon SM, Cariddi LN, Tonn CE, Sabini LI. Genotoxic evaluation of a methanolic extract of Verbascum thapsus using micronucleus test in mouse bone marrow. Nat Prod Commun. 2011;6(7):989-91. doi: 10.1177/1934578x1100600716.PubMedUsed to support: A methanolic V. thapsus extract at 100, 300 and 500 mg/kg did not increase micronucleated cells or show bone marrow toxicity in mice. A single animal assay that partly offsets, but does not replace, the missing genotoxicity testing of the flower.
  8. Castro AI, Carmona JB, Gonzales FG, Nestar OB. Occupational airborne dermatitis from gordolobo (Verbascum densiflorum). Contact Dermatitis. 2006;55(5):301. doi: 10.1111/j.1600-0536.2006.00923.x.PubMedUsed to support: A case report of occupational airborne dermatitis from mullein (gordolobo, Verbascum densiflorum), supporting the side-effect note on skin reactions from workplace exposure to the plant.
  9. Serkedjieva J. Combined antiinfluenza virus activity of Flos verbasci infusion and amantadine derivatives. Phytother Res. 2000;14(7):571-4. doi: 10.1002/1099-1573(200011)14:7<571::aid-ptr653>3.0.co;2-a.PubMedUsed to support: In tissue cultures, an infusion of V. thapsiforme flowers reduced the yields of a range of influenza viruses, and in chicken embryo fibroblast cultures combining it with three amantadine derivatives markedly enhanced its inhibition of an H7N7 influenza A strain. A cell-culture finding with no human participants. Supports the amantadine precaution.
  10. Committee on Herbal Medicinal Products (HMPC), European Medicines Agency. European Union herbal monograph on Verbascum thapsus L., V. densiflorum Bertol. (V. thapsiforme Schrad) and V. phlomoides L., flos (EMA/HMPC/611537/2016). European Medicines Agency. 2018;Final, adopted 27 March 2018..SourceUsed to support: Not PubMed-indexed (EU regulatory document). Traditional-use indication only: herbal tea for oral use to relieve symptoms of sore throat with dry cough and cold, based exclusively on long-standing use. Posology 1.5 to 2 g in 150 mL boiling water 3 to 4 times daily (4.5 to 8 g a day) for adolescents and adults; not recommended under 12 or in pregnancy and lactation; see a doctor if symptoms last over a week or if breathlessness, fever or purulent sputum occur; interactions none reported; undesirable effects none known; genotoxicity, reproductive toxicity and carcinogenicity tests not performed.
  11. Committee on Herbal Medicinal Products (HMPC), European Medicines Agency. Assessment report on Verbascum thapsus L., V. densiflorum Bertol. (V. thapsiforme Schrad) and V. phlomoides L., flos (EMA/HMPC/611531/2016). European Medicines Agency. 2018;Final, 27 March 2018..SourceUsed to support: Not PubMed-indexed (EU regulatory document). Reports no clinical pharmacology, efficacy or safety data for mullein flower; traditional role in cough and cold chiefly as a demulcent; 2 to 3 percent water-soluble polysaccharides and a swelling index of at least 9; iridoid, flavonoid, verbascoside and saponin contents by species; a flower water extract had no effect on mucociliary transport in frog tissue; aucubin and verbascoside anti-inflammatory and sedative effects in rodents; one suspected hepatitis report in WHO data to November 2017; no pharmacokinetic data.
  12. Committee on Herbal Medicinal Products (HMPC), European Medicines Agency. Addendum to Assessment report on Verbascum thapsus L.; V. densiflorum Bertol. (V. thapsiforme Schrad); V. phlomoides L., flos (EMA/HMPC/438161/2024). European Medicines Agency. 2024;Adopted 20 November 2024..SourceUsed to support: Not PubMed-indexed (EU regulatory document). Periodic review covering January 2017 to September 2024: 20 new references were identified and none was found relevant for the monograph, and EudraVigilance and VigiBase searches found no new safety issues. The 2018 monograph remains the current version.
  13. US Food and Drug Administration. 21 CFR 172.510 Natural flavoring substances and natural substances used in conjunction with flavors. Electronic Code of Federal Regulations. 2026;Title 21, Part 172, Section 172.510 (accessed 2026)..SourceUsed to support: Not PubMed-indexed (US federal regulation). Lists mullein flowers (Verbascum phlomoides L. or V. thapsiforme Schrad) among natural flavoring substances, with the limitation of use in alcoholic beverages only.
  14. Taleb S, Saeedi M. The effect of the Verbascum Thapsus on episiotomy wound healing in nulliparous women: a randomized controlled trial. BMC Complement Med Ther. 2021;21(1):166. doi: 10.1186/s12906-021-03339-6.PubMedUsed to support: Randomized, double-blind trial in 93 first-time mothers who applied a Verbascum thapsus cream or a placebo cream to the episiotomy wound twice daily for 10 days. Healing scores did not differ significantly on days 1 and 3 and were better with the mullein cream on day 10. A topical study, cited only to show that the randomized human data on mullein do not involve oral use.
  15. The Better Brand Inc. A Study to Evaluate the Effects of a Supplement on Mucus Clearance and Respiratory Symptoms (NCT07740746). ClinicalTrials.gov. 2026;Registry record first posted 3 August 2026, after a completion date of 30 August 2025; no results posted (accessed October 2026)..SourceUsed to support: Not PubMed-indexed (trial registry record). A randomized, triple-blind, placebo-controlled trial sponsored by the product's maker (collaborator Citruslabs) of a liquid made from mullein leaf and chlorophyll, 2 mL daily in water for 60 days, in 100 adults, with self-reported mucus clearance and respiratory symptoms as primary outcomes. It was registered after it ended, no results were posted, and no publication was found in PubMed as of October 2026.